首页> 外文期刊>Nephron >Calcium channel blockers inhibit proliferation and matrix production in rat mesangial cells: possible mechanism of suppression of AP-1 and CREB activities.
【24h】

Calcium channel blockers inhibit proliferation and matrix production in rat mesangial cells: possible mechanism of suppression of AP-1 and CREB activities.

机译:钙通道阻滞剂抑制大鼠系膜细胞的增殖和基质生成:抑制AP-1和CREB活性的可能机制。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Calcium channel blockers (CCBs) are reported to attenuate the loss of renal function in various glomerulonephritides. METHODS: To determine the mechanism of action of these drugs, we investigated the effects of CCBs on cell proliferation and extracellular matrix (ECM) production in cultured rat mesangial cells. RESULTS: While stimulation with 5% fetal calf serum (FCS) increased [(3)H]thymidine and [(3)H]proline incorporation into quiescent mesangial cells, incubation with nifedipine and cilnidipine inhibited the increase in a dose-dependent manner. Northern blot analysis demonstrated that 5% FCS increased the expression of transforming growth factor beta (TGF-beta) and fibronectin (FN) mRNA and that CCBs significantly reduced this induction, indicating that CCBs may reduce ECM production through inhibiting TGF-beta and FN. Since activator protein 1 (AP-1) regulates cell proliferation and TGF-beta expression, we evaluated the AP-1 activity by gel mobility shift analysis. Nuclear extracts of FCS-treated cells showed a strong binding to AP-1-specific oligonucleotides which was suppressed by CCBs, suggesting that these agents may inhibit cell proliferation by suppressing AP-1. CCBs also inhibited the binding activity of cyclic adenosine monophosphate responsive element binding protein which regulates FN gene expression. However, neither CCBs nor FCS affected the NFkappaB activity. CONCLUSION: These results suggest that CCBs may, in part, inhibit the progression of glomerulonephritis through non-hemodynamic actions that include the suppression of mesangial cell proliferation and the production of ECM. Copyright 2000 S. Karger AG, Basel
机译:背景:据报道,钙通道阻滞剂(CCBs)可减轻各种肾小球素肾病肾功能的丧失。方法:为了确定这些药物的作用机理,我们研究了CCBs对培养的大鼠系膜细胞的细胞增殖和细胞外基质(ECM)产生的影响。结果:虽然用5%胎牛血清(FCS)刺激使[(3)H]胸苷和[(3)H]脯氨酸掺入静止的系膜细胞中,但与硝苯地平和西尼地平一起孵育以剂量依赖的方式抑制了这种增加。 Northern印迹分析表明,5%FCS可增加转化生长因子β(TGF-beta)和纤连蛋白(FN)mRNA的表达,而CCB则显着降低了这种诱导作用,表明CCB可通过抑制TGF-beta和FN降低ECM的产生。由于激活蛋白1(AP-1)调节细胞增殖和TGF-β的表达,我们通过凝胶迁移率分析评估了AP-1的活性。经FCS处理的细胞的核提取物显示出与AP-1特异性寡核苷酸的强结合,而CCB抑制了它们的结合,这表明这些药物可通过抑制AP-1抑制细胞增殖。 CCB还抑制了调节FN基因表达的环状单磷酸腺苷响应元件结合蛋白的结合活性。但是,CCB和FCS均未影响NFkappaB的活性。结论:这些结果表明,CCBs可能通过非血流动力学作用部分抑制肾小球肾炎的进展,包括抑制系膜细胞增殖和产生ECM。版权所有2000 S. Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号